Skip to main content
Premium Trial:

Request an Annual Quote

Leena Peltonen, Craig Venter, Salvatore Salamone, Heino von Prondzynski, Werner Brandt, Franz Wirtz, Heinrich Hornef, Steve Lundy

Premium
The X Prize Foundation has appointed Leena Peltonen to the scientific advisory board of the Archon X Prize for Genomics.
 
Peltonen is a professor at the University of Helsinki and at the National Public Health Institute in Finland, and is a visiting professor at the Broad Institute of MIT and Harvard.

 
US Genomics announced that Craig Venter has stepped down from its board of directors and that Salvatore Salamone has joined it.
 
Salamone is currently chairman and CEO of Saladax BioMedical, a developer of chemotherapy-monitoring assays. Previously, he was vice president of R&D at Roche Diagnostics and senior vice president of R&D at Orasure Technologies.
 

 
Qiagen has nominated Heino von Prondzynski and Werner Brandt to the company’s supervisory board. They will stand for election at Qiagen’s annual meeting June 20.
 
Also at that meeting, Franz Wirtz and Heinrich Hornef will retire from their long-held positions on the company’s supervisory board.
 
Prondzynski was CEO of Roche Diagnostics and a member of Roche’s executive committee and was CEO and general manager at Chiron.
 
Brandt was chief financial officer at SAP and was a member of SAP’s executive board. He also was CFO of Frenesius Medical Care and formerly worked in finance at Price Waterhouse Coopers.
 

 
Ciphergen has named Steve Lundy senior vice president of sales and marketing, the company said last week.
 
Lundy comes to Ciphergen from GeneOhm, where he was vice president of sales and marketing. He had worked earlier as vice president of marketing at Esoterix and was marketing director of molecular diagnostics and critical care testing at Bayer Diagnostics.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.